FNAM — Evolutionary Genomics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro Cap

Annual balance sheet for Evolutionary Genomics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	0.16	0.087	0.216	0.214	0.577
Net Total Accounts Receivable
Net Total Receivables	0.04	0.007	0	—	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	0.223	0.118	0.278	0.256	0.699
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.127	0.089	0.051	0.019	0.004
Net Intangible Assets
Total Assets	4.39	4.24	3.99	2.93	2.35
Payable / Accrued
Notes Payable / Short Term Debt
Total Current Liabilities	0	0.019	0.003	0.019	0.178
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Liabilities	0.955	1.01	2.25	3.76	3.92
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	3.43	3.24	1.74	-0.831	-1.57
Total Liabilities & Shareholders' Equity	4.39	4.24	3.99	2.93	2.35
Total Common Shares Outstanding
Total Preferred Shares Outstanding